Transcript Chapter 44
Chapter 44
Drugs Used for Cancer Treatment
Mosby items and derived items © 2013, 2010, 2007, 2004 by
Mosby, Inc., an affiliate of Elsevier Inc.
44-1
Lesson 44.1
Mosby items and derived items © 2013, 2010, 2007, 2004 by
Mosby, Inc., an affiliate of Elsevier Inc.
44-2
Objectives
Identify common sites for cancer in men and
women and cite the goals of chemotherapy.
Cite the rationale for giving chemotherapeutic
drugs on a precise time schedule.
Describe the nursing assessments and
interventions needed for people experiencing
adverse effects from chemotherapy.
Mosby items and derived items © 2013, 2010, 2007, 2004 by
Mosby, Inc., an affiliate of Elsevier Inc.
44-3
Cancer and the Use of
Antineoplastic Agents
Cancer: disorder of cellular growth
Occurs when a group of abnormal cells proliferates
more rapidly than normal cells, losing the ability to
perform specialized functions
They invade surrounding tissues, and develop
growths in other tissues distant to the original growth
(metastasis)
Treatment requires combination of surgery, radiation,
chemotherapy, and immunotherapy
Recent developments enhance role of antineoplastic
agents in therapy
Mosby items and derived items © 2013, 2010, 2007, 2004 by
Mosby, Inc., an affiliate of Elsevier Inc.
44-4
Cancer Cases and Deaths
Mosby items and derived items © 2013, 2010, 2007, 2004 by
Mosby, Inc., an affiliate of Elsevier Inc.
44-5
Audience Response Question 1
Which type of cancer is the leading cause of
cancer-related death in women?
A.
B.
C.
D.
Breast
Colon
Lung
Ovary
Mosby items and derived items © 2013, 2010, 2007, 2004 by
Mosby, Inc., an affiliate of Elsevier Inc.
44-6
Phases of Cell Growth
Mitosis: phase of cellular proliferation in which cells
divide into two equal daughters
Cells either advance into nonproliferative stage (G0), or
advance to first gap phase (G1)
Stimulation is needed to enter G1 phase
Phase G1: presynthetic phase in which the cell
manufactures needed enzymes to prepare for DNA
synthesis
Phase G2: postsynthetic phase in which the cell prepares for
mitosis by producing RNA, specialized proteins, and
foundations for the mitotic spindle apparatus needed for
mitosis
Mosby items and derived items © 2013, 2010, 2007, 2004 by
Mosby, Inc., an affiliate of Elsevier Inc.
44-7
Phases of Cell Growth (cont.)
Phase G2 (cont.)
• Mitosis divides the cell into two G1 daughter cells
• G1 cells may advance again to S phase or pass into a
nonproliferative stage known as G0
S phase: stage of active synthesis of two sets of
DNA
Generation time: time required to complete a
cycle
Mosby items and derived items © 2013, 2010, 2007, 2004 by
Mosby, Inc., an affiliate of Elsevier Inc.
44-8
Cell Cycle and Effects of Drugs
Cell cycle–specific
Drug is selectively toxic when the cell is in a
specific phase of growth—schedule dependent
Effective against malignancies that proliferate
rapidly
Cell cycle–nonspecific
Active throughout the cell cycle
More effective against slowly proliferating
neoplastic tissue
Mosby items and derived items © 2013, 2010, 2007, 2004 by
Mosby, Inc., an affiliate of Elsevier Inc.
44-9
Audience Response Question 2
By which method does cell cycle–specific
treatment therapy work?
A.
B.
C.
D.
Treating cancer cells at their vulnerable cell
reproductive stage
Affecting a cancer cell throughout its entire life
cycle
Inhibiting slowly growing cancer cells
Targeting key pathways that provide growth to
cancer cells
Mosby items and derived items © 2013, 2010, 2007, 2004 by
Mosby, Inc., an affiliate of Elsevier Inc.
44-10
Drug Therapy for Cancer
Goals for chemotherapy
Give a dose large enough to be lethal to cancer
cells but small enough to be tolerable for normal
cells
Control of the disease (arresting of tumor)
Goal for palliation: alleviation of symptoms if
cancer is beyond control
Goal for prophylaxis: prophylactic measures if
patient is a known risk for developing cancer
Mosby items and derived items © 2013, 2010, 2007, 2004 by
Mosby, Inc., an affiliate of Elsevier Inc.
44-11
Nursing Assessments
History of risk factors
Dietary habits
Preexisting health problems
Adaptation to diagnosis
Psychomotor functions
Safety
Symptoms of pharmacologic adverse effects
Physical and sexual assessment
Pain
Mosby items and derived items © 2013, 2010, 2007, 2004 by
Mosby, Inc., an affiliate of Elsevier Inc.
44-12
Nursing Interventions
Plan care based on assessment data and
individual needs of patient; monitor VS
Examine lab tests
Monitor for development of emergencies
Monitor hydration status
Report early signs of infection
Nausea and vomiting are common
Preadminister antiemetic; report poor control,
monitor hydration and electrolyte status
Mosby items and derived items © 2013, 2010, 2007, 2004 by
Mosby, Inc., an affiliate of Elsevier Inc.
44-13
Nursing Interventions (cont.)
Monitor for changes in bowel movements
Meticulous oral hygiene for stomatitis
Report bleeding
Give pain medications at intervals to maintain
maximum pain control
Nutritional needs
Encourage patient/family to discuss concerns
with support group; allow choices
Mosby items and derived items © 2013, 2010, 2007, 2004 by
Mosby, Inc., an affiliate of Elsevier Inc.
44-14
Nursing Interventions (cont.)
Sexual needs: discuss birth control during
chemotherapy and/or sperm storage
Vascular access devices
Skin care to prevent skin breakdown
Mosby items and derived items © 2013, 2010, 2007, 2004 by
Mosby, Inc., an affiliate of Elsevier Inc.
44-15
Patient Education
Neutropenia: discuss handwashing; avoiding
infected individuals; no fresh flowers,
vegetables, pets, items with free-standing
water, those receiving immunizations
Pain: report pain that is new or not controlled,
take medications at prescribed intervals to
obtain maximum relief
Anemia: space activities and rest
Thrombocytopenia: monitor for bleeding
episodes; avoid sharps, ASA, anticoagulants
Mosby items and derived items © 2013, 2010, 2007, 2004 by
Mosby, Inc., an affiliate of Elsevier Inc.
44-16
Audience Response Question 3
A patient has developed thrombocytopenia
following a round of chemotherapy. The
nurse should instruct the patient to:
use an electric razor to shave.
B. wash his hands frequently.
C. plan his activities to allow rest time.
D. report temperature elevations.
A.
Mosby items and derived items © 2013, 2010, 2007, 2004 by
Mosby, Inc., an affiliate of Elsevier Inc.
44-17
Lesson 44.2
Mosby items and derived items © 2013, 2010, 2007, 2004 by
Mosby, Inc., an affiliate of Elsevier Inc.
44-18
Objectives
Identify which types of chemotherapeutic
agents are cell cycle–specific and which are
cell cycle–nonspecific.
Describe the role of targeted anticancer
agents in treating cancer.
Describe the role of chemoprotective agents
in treating cancer.
Describe the role of bone marrow stimulants
in treating cancer.
Mosby items and derived items © 2013, 2010, 2007, 2004 by
Mosby, Inc., an affiliate of Elsevier Inc.
44-19
Drug Class: Alkylating Agents
Actions
Highly reactive chemical compounds that bond with DNA
molecules, causing cross-linking of DNA strands; binding
prevents separation of the double-coiled DNA molecules
necessary for cellular division
Uses
Treat chronic lymphocytic leukemia, ovarian cancer, brain
tumors, Hodgkin’s disease, non-Hodgkin’s lymphoma,
multiple myeloma
Serious adverse effects
Bone marrow depression, nephrotoxicity
Mosby items and derived items © 2013, 2010, 2007, 2004 by
Mosby, Inc., an affiliate of Elsevier Inc.
44-20
Audience Response Question 4
A patient has been taking an alkylating agent
for chemotherapy to treat ovarian cancer. The
care plan mentions observing for
nephrotoxicity during treatment. The nurse
should monitor for development of:
jaundiced skin and sclera.
B. decreased urine output.
C. increased liver enzymes.
D. frequent bleeding episodes.
A.
Mosby items and derived items © 2013, 2010, 2007, 2004 by
Mosby, Inc., an affiliate of Elsevier Inc.
44-21
Drug Class: Antimetabolites
Actions
Inhibit key enzymes in the biosynthetic pathways
of DNA and RNA synthesis
Uses
Treat breast cancer; colon cancer; hairy cell
leukemia, lymphomas, acute lymphocytic
leukemia, myelodysplastic syndromes
Serious adverse effects
Bone marrow depression, petechiae,
hepatotoxicity, dermatitis, stomatitis
Mosby items and derived items © 2013, 2010, 2007, 2004 by
Mosby, Inc., an affiliate of Elsevier Inc.
44-22
Drug Class: Natural Products
Actions
Cell cycle–specific agents block formation of the
mitotic spindle during mitosis, inhibiting cell
division
Uses
Treat Hodgkin's disease; non-Hodgkin’s
lymphoma; acute lymphocytic leukemia; Kaposi’s
sarcoma; ovarian, breast, testicular cancers
Serious adverse effects
Bone marrow depression, peripheral neuropathy,
hepatotoxicity
Mosby items and derived items © 2013, 2010, 2007, 2004 by
Mosby, Inc., an affiliate of Elsevier Inc.
44-23
Drug Class:
Antineoplastic Antibiotics
Actions
Bind to DNA, inhibiting DNA or RNA synthesis
Uses
Hodgkin’s disease, non-Hodgkin’s lymphoma;
squamous cell, head and neck, testicular cancers;
Wilms’ tumor; rhabdomyosarcoma; Ewing’s and
osteogenic sarcoma; acute lymphocytic leukemia;
acute myeloid leukemia
Serious adverse effects
Bone marrow depression, hepatotoxicity,
stomatitis, cardiotoxicity
Mosby items and derived items © 2013, 2010, 2007, 2004 by
Mosby, Inc., an affiliate of Elsevier Inc.
44-24
Drug Class: Hormones
Actions
Reduce edema secondary to radiation therapy
and act as palliative therapy; temporarily suppress
fever, diaphoresis, and pain
Uses
Estrogens and androgens used in malignancies of
sexual organs
Serious adverse effects
Gynecomastia, hot flashes, diarrhea, pelvic pain,
edema, hepatitis, thrombosis, hyperglycemia
Mosby items and derived items © 2013, 2010, 2007, 2004 by
Mosby, Inc., an affiliate of Elsevier Inc.
44-25
Drug Therapy for Cancer
Targeted anticancer agents
Act on receptors to target key pathways that
provide growth and survival advantages for cancer
cells
Not associated with toxicities common with
cytotoxic chemotherapy
Chemoprotective agents
Reduce toxicity of chemotherapeutic agents to
normal cells
Mosby items and derived items © 2013, 2010, 2007, 2004 by
Mosby, Inc., an affiliate of Elsevier Inc.
44-26
Drug Therapy for Cancer (cont.)
Bone marrow stimulants: trigger recovery of
bone marrow cells
Davepoetin and epoetin stimulate bone marrow to
produce RBCs to treat anemia
Filgrastim, pegfilgrastim stimulate production of
neutrophilic white blood cells
Oprelvekin stimulates platelet production
Mosby items and derived items © 2013, 2010, 2007, 2004 by
Mosby, Inc., an affiliate of Elsevier Inc.
44-27
Audience Response Question 5
Which bone marrow stimulant increases the
production of white blood cells?
A.
B.
C.
D.
Filgrastim (Neupogen)
Epoetin alpha (Epogen)
Darbepoetin (Aranesp)
Oprelvekin (Neumega)
Mosby items and derived items © 2013, 2010, 2007, 2004 by
Mosby, Inc., an affiliate of Elsevier Inc.
44-28